Laden…
8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Alprazolam is a benzodiazepine primarily used for the treatment of anxiety disorders and panic disorders. It acts by enhancing GABA-mediated inhibition in the central nervous system, leading to calming, anxiolytic, and muscle-relaxing effects. Due to its potential for dependence and withdrawal symptoms, cautious use is recommended.
Class
Depressiva
Pharmacological context
Mechanism
Alprazolam acts as an agonist at the GABA-A receptor, which enhances...
Short read on known pharmacology
Interactions
1 documented
Curated visible combinations
Risk theme
1 high-risk interaction
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: Alprazolam
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der GABA-A-Rezeptor ist ein ligandengesteuerter Chloridkanal und der wichtigste inhibitorische Rezeptor im zentralen Nervensystem. Er besitzt multiple allosterische Bindungsstellen für verschiedene Substanzklassen.
Synapedia Evidence
Alprazolam acts as an agonist at the GABA-A receptor, which enhances the inhibitory effect of GABA in the central nervous system. This leads to a reduction in anxiety and a calming of the nervous system.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 0.5–1 mg
Total duration 6–12 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 0.25 mg |
| Reported | 0.5–1 mg |
| Strong | 2 mg |
Oral
Onset
30–60 minutes
Peak
1–2 hours
Total duration
6–12 hours
After effects
2–4 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Alprazolam kann zu Abhängigkeit führen und hat ein Risiko für Missbrauch.
Safer Use
Depressant-risk context
This substance belongs to a context where combinations with opioids, benzodiazepines, alcohol, GHB/GBL, or other sedating substances can increase sedation, blackout, aspiration, and breathing-risk patterns. Risk Check can review warning patterns; it is not medical advice and it cannot clear a combination as safe.
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Some combinations can be dangerous. Research before combining substances. For breathing problems, unconsciousness, seizures, chest pain, high fever, or severe confusion, contact emergency services.
Life-Threatening: Extreme CNS Depression from Short-Acting Benzodiazepine and Alcohol
Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.